H Thiele

Summary

Affiliation: University of Leipzig
Country: Germany

Publications

  1. Mebazaa A, Combes A, van Diepen S, Hollinger A, Katz J, Landoni G, et al. Management of cardiogenic shock complicating myocardial infarction. Intensive Care Med. 2018;: pubmed publisher
    ..complicating acute coronary syndromes with a focus on (a) potential therapeutic issues from the perspective an interventional cardiologist, an emergency physician, and an intensive care physician, (b) the type of revascularization, and ..
  2. Feistritzer H, Desch S, de Waha S, Jobs A, Zeymer U, Thiele H. German contribution to development and innovations in the management of acute myocardial infarction and cardiogenic shock. Clin Res Cardiol. 2018;: pubmed publisher
  3. Fuernau G, Beck J, Desch S, Eitel I, Jung C, Erbs S, et al. Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction - The Randomized SHOCK-COOL Trial. Circulation. 2018;: pubmed publisher
    ..b>Clinical Trial Registration -URL: www.clinicaltrials.gov Unique Identifier: NCT01890317. ..
  4. Abdin A, Pöss J, Fuernau G, Ouarrak T, Desch S, Eitel I, et al. Revision: prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock-a substudy of the IABP-SHOCK II-trial. Clin Res Cardiol. 2018;107:517-523 pubmed publisher
    ..In patients with CS complicating AMI, increased glucose concentration at admission was an independent predictor for mortality at 30-days and 1-year, independently of the diabetic state. ..
  5. Jobs A, Mehta S, Montalescot G, Vicaut E, van T Hof A, Badings E, et al. Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials. Lancet. 2017;390:737-746 pubmed publisher
    ..An early invasive strategy does not reduce mortality compared with a delayed invasive strategy in all patients with NSTE-ACS. However, an early invasive strategy might reduce mortality in high-risk patients. None. ..
  6. Thiele H. [Cardiogenic shock : Current evidence]. Herz. 2017;: pubmed publisher
    ..The use of percutaneous implantable mechanical circulatory support devices has not shown a survival benefit in the few randomized trials carried out so far even when compared with IABP, due to increased bleeding complications. ..
  7. Thiele H, Desch S, de Waha S. [Acute myocardial infarction in patients with ST-segment elevation myocardial infarction : ESC guidelines 2017]. Herz. 2017;42:728-738 pubmed publisher